Traws Pharma, Inc.
TRAW
Last
$0.45
Day
-6.8%
1y
-84.7%
5y
-99.5%
52w
-85.3%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-11-1232d
EMA 21
0.53
EMA 50
0.59
EMA 200
1.22
20d high
-31.3%
5y high
-99.5%
5y range
0th
Positions held
Your positionsTRAW isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
-12
Hold
avoid
Signal
Sell
Target
$0.58
Stop
$0.39
Stop distance
12.8%
Target vs last
+29.6%
Fundamentals
| Market cap | $7.38M | Enterprise value | $2.37M | Trailing P/E | — | Forward P/E | -0.26 |
| PEG | — | Price / book | 4.33 | Beta | 1.53 | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | -4.3% | ROA | -99.4% | Debt / equity | — |
| Current ratio | 0.93 | Free cash flow | -$13.33M | Analyst recommendation | none | Mean target | $1.00 |
| 52w high | $3.27 | 52w low | $0.43 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | $2.7M | — |
| Op margin | — | — | — | — | -45.7% | — |
| Net income | -$3.1M | -$7.1M | -$7.4M | -$4.0M | -$0.9M | — |
| Gross margin | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$3.2M | -$6.9M | -$7.4M | -$4.1M | -$1.2M | — |
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $2.8M | $0.2M | $0.2M | $0.2M | — |
| Op margin | -640.7% | -11022.1% | -8981.4% | -8684.5% | — |
| Net income | $9.2M | -$167M | -$18.9M | -$19.0M | — |
| Gross margin | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$17.9M | -$24.9M | -$20.3M | -$19.6M | — |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
Price (daily)
Full chart · RSI · MACD · patternsTRAW · daily-3.9% over 13 sessions
Close EMA21 EMA50 EMA200
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin